High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control

被引:94
作者
Neumann, T. [1 ]
Lodes, S. [1 ]
Kaestner, B. [1 ]
Franke, S. [1 ]
Kiehntopf, M. [2 ,3 ]
Lehmann, T. [4 ]
Mueller, U. A. [1 ]
Wolf, G. [1 ]
Saemann, A. [1 ]
机构
[1] Jena Univ Hosp, Dept Internal Med 3, D-07747 Jena, Germany
[2] Jena Univ Hosp, Inst Clin Chem, Jena, Germany
[3] Jena Univ Hosp, Diagnost Lab, Jena, Germany
[4] Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, D-07747 Jena, Germany
关键词
Fractures; Type; 1; diabetes; Pentosidine; GLYCATION END-PRODUCTS; NONENZYMATIC GLYCATION; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; RISK; ENDPRODUCTS; RECEPTOR; CARBOXYMETHYLLYSINE; COMPLICATIONS; RETINOPATHY;
D O I
10.1007/s00198-014-2631-7
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Fracture risk in type 1 diabetes (T1D) is supposed to be underestimated by bone mineral density (BMD). Individuals with T1D had more prevalent fractures in a cross-sectional study. Serum levels of pentosidine, an advanced glycation end product, and poor glycaemic control were associated with prevalent fractures independent of BMD. Type 1 diabetes (T1D) is associated with increased fracture risk. Bone mineral density (BMD) underestimates the risk of fractures in some individuals. The accumulation of advanced glycation end products (AGEs) impairs bone matrix and reduces bone strength. In a cross-sectional study, 128 men and premenopausal women with T1D were evaluated. We compared traditional risk factors for fractures, BMD, parameters of bone metabolism and AGEs in individuals with and without prevalent fractures. An independent association of serum AGE levels with prevalent fractures was investigated. Individuals with prevalent fractures exhibited a longer duration of T1D, higher HbA1c and more diabetic-related complications. BMD at the femoral neck (z-score -0.76 +/- 0.94 vs. -0.23 +/- 1.02; p = 0.031) and total hip (z-score -0.54 +/- 0.93 vs. 0.11 +/- 1.11; p = 0.017) was lower in those with prevalent fractures. Individuals with fractures had higher pentosidine levels (164.1 +/- 53.6 vs. 133.2 +/- 40.4; p = 0.002). The levels of N-epsilon-(carboxymethyl)-lysine (CML) and endogenous secretory receptor for AGEs (esRAGE) did not significantly differ. Multivariate logistic regression analysis adjusted for age, BMI, family history of fractures, smoking, vitamin D deficiency, BMD at lumbar spine, femoral neck and total hip identified pentosidine levels and HbA1c as independent factors associated with prevalent fractures (odds ratio 1.02, 95 % CI 1.00-1.03/pmol/ml increase of pentosidine; p = 0.008 and odds ratio 1.93, 95 % CI 1.16-3.20 per percentage increase of HbA1c; p = 0.011). The pentosidine levels but not BMD are independently associated with prevalent fractures. Impaired bone quality in T1D may result from increased AGE formation.
引用
收藏
页码:1527 / 1533
页数:7
相关论文
共 33 条
[21]
Pentosidine - A New Biochemical Marker in Diabetic Retinopathy [J].
Salman, Abdelrahman Gaber ;
Mansour, Dina Ezzat Abdel Aziz ;
Swelem, Al-Hussein Ali ;
Al-Zawahary, Walid Mohamed Abdel-Raaouf ;
Radwan, Ahmad Abdelmegid .
OPHTHALMIC RESEARCH, 2009, 42 (02) :96-98
[22]
Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes [J].
Schwartz, Ann V. ;
Garnero, Patrick ;
Hillier, Teresa A. ;
Sellmeyer, Deborah E. ;
Strotmeyer, Elsa S. ;
Feingold, Kenneth R. ;
Resnick, Helaine E. ;
Tylavsky, Frances A. ;
Black, Dennis M. ;
Cummings, Steven R. ;
Harris, Tamara B. ;
Bauer, Douglas C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07) :2380-2386
[23]
Mechanisms of disease - Bone quality - The material and structural basis of bone strength and fragility [J].
Seeman, Ego ;
Delmas, Pierre D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (21) :2250-2261
[24]
Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration The Joslin 50-Year Medalist Study [J].
Sun, Jennifer K. ;
Keenan, Hillary A. ;
Cavallerano, Jerry D. ;
Asztalos, Bela F. ;
Schaefer, Ernst J. ;
Sell, David R. ;
Strauch, Christopher M. ;
Monnier, Vincent M. ;
Doria, Alessandro ;
Aiello, Lloyd Paul ;
King, George L. .
DIABETES CARE, 2011, 34 (04) :968-974
[25]
Urinary Pentosidine Improves Risk Classification Using Fracture Risk Assessment Tools for Postmenopausal Women [J].
Tanaka, Shiro ;
Kuroda, Tatsuhiko ;
Saito, Mitsuru ;
Shiraki, Masataka .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (11) :2778-2784
[26]
Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation [J].
Valcourt, Ulrich ;
Merle, Blandine ;
Gineyts, Evelyne ;
Viguet-Carrin, Stephanie ;
Delmas, Pierre D. ;
Garnero, Patrick .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5691-5703
[27]
Influence of nonenzymatic glycation on biomechanical properties of cortical bone [J].
Vashishth, D ;
Gibson, GJ ;
Khoury, JI ;
Schaffler, MB ;
Kimura, J ;
Fyhrie, DP .
BONE, 2001, 28 (02) :195-201
[28]
Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62
[30]
Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes [J].
Yamamoto, Masahiro ;
Yamaguchi, Toru ;
Yamauchi, Mika ;
Yano, Shozo ;
Sugimoto, Toshitsugu .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) :1013-1019